European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2025
Critical issues in bone anchored hearing aids.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Dalè Michael, Buono Francesco, Simoni Federica, Pennacchi Alessia, Ferrari Elena, Corbo Daniele, Valentina Santomauro, Castello Eolo Mario
Аннотация
PURPOSE: This study investigates the audiological performance and user satisfaction of bone-anchored hearing aids (BAHA). It addresses four key aspects: comparison with conventional hearing aids, differences between percutaneous and transcutaneous devices, benefits in unilateral hearing loss, and the patient adaptation process.
METHODS: Between January 2023 and June 2024, 40 patients with conductive and mixed hearing loss received BAHA implants. Audiological evaluations included pure-tone and free-field audiometry, the Italian Matrix Sentence Test, and satisfaction questionnaires.
RESULTS: BAHA significantly improved hearing thresholds, speech recognition, and signal-to-noise ratios compared to the unaided situation and to the conventional hearing aid use, with sustained benefits over 3 months. Questionnaire scores confirmed enhanced patient-reported outcomes.
CONCLUSION: Significant improvements were noted in audiometric and subjective outcomes, with BAHA outperforming conventional hearing aids in noise. Percutaneous devices showed better high-frequency performance, but both systems provided similar speech-in-noise benefits. BAHA also enhanced binaural hearing in unilateral loss. Audiologic results at 3 and 6 months are similar: after 3 months BAHA use, adaptation is complete.
METHODS: Between January 2023 and June 2024, 40 patients with conductive and mixed hearing loss received BAHA implants. Audiological evaluations included pure-tone and free-field audiometry, the Italian Matrix Sentence Test, and satisfaction questionnaires.
RESULTS: BAHA significantly improved hearing thresholds, speech recognition, and signal-to-noise ratios compared to the unaided situation and to the conventional hearing aid use, with sustained benefits over 3 months. Questionnaire scores confirmed enhanced patient-reported outcomes.
CONCLUSION: Significant improvements were noted in audiometric and subjective outcomes, with BAHA outperforming conventional hearing aids in noise. Percutaneous devices showed better high-frequency performance, but both systems provided similar speech-in-noise benefits. BAHA also enhanced binaural hearing in unilateral loss. Audiologic results at 3 and 6 months are similar: after 3 months BAHA use, adaptation is complete.